Our previous studies have demonstrated that epidermal growth factor receptor (EGFR) promotes the development and progression of peritoneal fibrosis via the activation of multiple pro-fibrosis signaling pathways, inflammatory responses and angiogenesis (7). This evidence concerns the gene EGFR and Peritoneal Fibrosis.